DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Burak KW, Swain MG, Santodomingo-Garzon T. , et al.
Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.
Can J Gastroenterol 2013;
27 (05) 273-280
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.